2-linoleoylglycerol and 2-palmitoylglycerol

2-linoleoylglycerol has been researched along with 2-palmitoylglycerol* in 4 studies

Other Studies

4 other study(ies) available for 2-linoleoylglycerol and 2-palmitoylglycerol

ArticleYear
2-Arachidonoylglycerol as a possible treatment for anorexia nervosa in animal model in mice.
    Brain research, 2017, Sep-01, Volume: 1670

    We have investigated the effects of 0.001mg/kg 2-arachidonoylglycerol (2-AG) administered in combination with compounds present in the body alongside 2-AG like 2-palmitoylglycerol and 2-linoleylglycerol (also termed "entourage"), on cognitive function,food intake, and neurotransmitter levels in the hippocampus and hypothalamus of mice under diet restriction. Young female Sabra mice were treated with vehicle, 2-AG, 2-AG+entourage, 2-AG+entourage+5-(4-Chlorophenyl)-1-(2,4-dichloro-phenyl)- 4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (SR141716A, a CB

    Topics: Animals; Anorexia Nervosa; Arachidonic Acids; Cannabinoid Receptor Modulators; Cognition; Disease Models, Animal; Dopamine; Eating; Endocannabinoids; Female; Glycerides; Hippocampus; Hypothalamus; Levodopa; Mice; Neurotransmitter Agents; Random Allocation

2017
Where's my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol.
    Pharmacological research, 2016, Volume: 110

    2-Arachidonoylglycerol (2-AG) is the most abundant endogenous cannabinoid in the brain and an agonist at two cannabinoid receptors (CB1 and CB2). The synthesis, degradation and signaling of 2-AG have been investigated in detail but its relationship to other endogenous monoacylglycerols has not been fully explored. Three congeners that have been isolated from the CNS are 2-linoleoylglycerol (2-LG), 2-oleoylglycerol (2-OG), and 2-palmitoylglycerol (2-PG). These lipids do not orthosterically bind to cannabinoid receptors but are reported to potentiate the activity of 2-AG, possibly through inhibition of 2-AG degradation. This phenomenon has been dubbed the 'entourage effect' and has been proposed to regulate synaptic activity of 2-AG. To clarify the activity of these congeners of 2-AG we tested them in neuronal and cell-based signaling assays. The signaling profile for these compounds is inconsistent with an entourage effect. None of the compounds inhibited neurotransmission via CB1 in autaptic neurons. Interestingly, each failed to potentiate 2-AG-mediated depolarization-induced suppression of excitation (DSE), behaving instead as antagonists. Examining other signaling pathways we found that 2-OG interferes with agonist-induced CB1 internalization while 2-PG modestly internalizes CB1 receptors. However in tests of pERK, cAMP and arrestin recruitment, none of the acylglycerols altered CB1 signaling. Our results suggest 1) that these compounds do not serve as entourage compounds under the conditions examined, and 2) that they may instead serve as functional antagonists. Our results suggest that the relationship between 2-AG and its congeners is more nuanced than previously appreciated.

    Topics: Animals; Arrestin; Cannabinoid Receptor Antagonists; Cell Line; Cyclic AMP; Dose-Response Relationship, Drug; Endocannabinoids; Extracellular Signal-Regulated MAP Kinases; Glycerides; Hippocampus; Humans; Mice; Neurons; Phosphorylation; Receptor, Cannabinoid, CB1; Synaptic Transmission; Time Factors; Transfection

2016
2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice.
    European journal of pharmacology, 2000, Oct-06, Volume: 406, Issue:1

    2-Arachidonylglycerol (2-AG) inhibits the production in vitro of tumor necrosis factor-alpha (TNF-alpha) by mouse macrophages, as well as in mice. It has no effect on the production of nitric oxide (NO). The effect on TNF-alpha is enhanced when 2-AG is administered together with 2-linoleylglycerol (2-Lino-G) and 2-palmitylglycerol (2-PalmG), an 'entourage effect' previously noted in several behavioral and binding assays. 2-AG also suppresses the formation of radical oxygen intermediates.

    Topics: Animals; Arachidonic Acids; Cannabinoids; Cell Line; Dose-Response Relationship, Drug; Drug Synergism; Endocannabinoids; Glycerides; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Tumor Necrosis Factor-alpha

2000
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.
    European journal of pharmacology, 1998, Jul-17, Volume: 353, Issue:1

    2-Arachidonoyl-glycerol (2-Ara-GI) has been isolated from various tissues and identified as an endogenous ligand for both cannabinoid receptors, CB1 and CB2. Here we report that in spleen, as in brain and gut, 2-Ara-GI is accompanied by several 2-acyl-glycerol esters, two major ones being 2-linoleoyl-glycerol (2-Lino-Gl) and 2-palmitoyl-glycerol (2-Palm-Gl). These two esters do not bind to the cannabinoid receptors, nor do they inhibit adenylyl cyclase via either CB1 or CB2; however, they significantly potentiate the apparent binding of 2-Ara-Gl and its apparent capacity to inhibit adenylyl cyclase. Together these esters also significantly potentiate 2-Ara-Gl inhibition of motor behavior, immobility on a ring, analgesia on a hot plate and hypothermia caused by 2-Ara-Gl in mice. 2-Lino-Gl, but not 2-Palm-GI, significantly inhibits the inactivation of 2-Ara-Gl by neuronal and basophilic cells. These data indicate that the biological activity of 2-Ara-Gl can be increased by related, endogenous 2-acyl-glycerols, which alone show no significant activity in any of the tests employed. This effect ('entourage effect') may represent a novel route for molecular regulation of endogenous cannabinoid activity.

    Topics: Adenylyl Cyclase Inhibitors; Analgesics; Animals; Arachidonic Acids; Cannabinoids; Cell Line; COS Cells; Drug Synergism; Endocannabinoids; Enzyme Inhibitors; Female; Gas Chromatography-Mass Spectrometry; Glycerides; Hydrolysis; Hypothermia; Ligands; Mice; Motor Activity; Pain Measurement; Receptors, Cannabinoid; Receptors, Drug; Spleen

1998